Proto Labs (PRLB)
(Delayed Data from NYSE)
$31.37 USD
-0.05 (-0.16%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $31.40 +0.03 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Income Statements
Fiscal Year end for Proto Labs, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 504 | 488 | 488 | 434 | 459 |
Cost Of Goods | 282 | 273 | 265 | 217 | 223 |
Gross Profit | 222 | 215 | 223 | 218 | 235 |
Selling & Adminstrative & Depr. & Amort Expenses | 194 | 313 | 182 | 158 | 155 |
Income After Depreciation & Amortization | 28 | -98 | 40 | 60 | 80 |
Non-Operating Income | 0 | 0 | 0 | 3 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 28 | -98 | 40 | 63 | 81 |
Income Taxes | 11 | 6 | 7 | 12 | 18 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 17 | -103 | 33 | 51 | 64 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 17 | -103 | 33 | 51 | 64 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 66 | -59 | 81 | 93 | 111 |
Depreciation & Amortization (Cash Flow) | 38 | 39 | 40 | 33 | 31 |
Income After Depreciation & Amortization | 28 | -98 | 40 | 60 | 80 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 26.22 | 27.41 | 27.65 | 26.90 | 27.05 |
Diluted EPS Before Non-Recurring Items | 0.66 | -3.77 | 1.21 | 1.89 | 2.35 |
Diluted Net EPS (GAAP) | 0.66 | -3.77 | 1.21 | 1.89 | 2.35 |
Fiscal Year end for Proto Labs, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 125.05 | 130.71 | 122.27 | 125.86 |
Cost Of Goods | NA | 69.24 | 71.42 | 69.14 | 72.08 |
Gross Profit | NA | 55.81 | 59.28 | 53.12 | 53.78 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 47.42 | 48.87 | 47.52 | 50.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8.39 | 10.41 | 5.60 | 3.75 |
Non-Operating Income | NA | 1.54 | 0.32 | -3.37 | 1.29 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 9.94 | 10.74 | 2.24 | 5.04 |
Income Taxes | NA | 2.95 | 2.78 | 2.62 | 2.38 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 6.99 | 7.95 | -0.38 | 2.66 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 6.99 | 7.95 | -0.38 | 2.66 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 25.89 | 26.03 | 26.21 | 26.61 |
Diluted EPS Before Non-Recurring Items | NA | 0.27 | 0.31 | -0.01 | 0.10 |
Diluted Net EPS (GAAP) | NA | 0.26 | 0.31 | -0.01 | 0.10 |